EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 8 (2022) SICOT-J, 8 (2022) 42 Full HTML
Open Access
Issue
SICOT-J
Volume 8, 2022
Article Number 42
Number of page(s) 7
Section Spine
DOI https://doi.org/10.1051/sicotj/2022042
Published online 25 October 2022

© The Authors, published by EDP Sciences, 2022

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

Low back pain (LBP) is the leading worldwide cause of years lost to disability [1]. The sacroiliac joint (SIJ) plays a role in 15–30% of these patients and even a higher percentage in patients who have had previous lumbar fusion [2]. The effect of SIJ dysfunction on the quality of life is comparable to other well-recognized preoperative Orthopaedic conditions such as lumbar spinal stenosis and degenerative hip arthritis [3].

Conservative management is the first line of treatment. It is not effective in the long run [4, 5], failing to achieve the Minimal Clinical Important Difference (MCID) in 75–90% of patients, and is associated with increased use of opioids [2, 6, 7].

Fusion is the surgical procedure of choice in resistant cases. Minimally invasive (MI) SIJ fusion has been shown to have lower operative blood loss, hospital stay, surgical time, and better pain relief compared to open SIJ fusion [8, 9]. This low morbidity intervention led to a reignited interest in this often forgotten joint with early promising results [2, 6] (Tables 1–3).

A meta-analysis evaluating the quality of evidence in fourteen publications on a commercially available system rated the available evidence as poor [10]. Shamrock et al. reported in a systematic review that seven articles received industry- sponsored funding, and eight articles had at least one author with a relevant disclosure [11].

To our knowledge, the results of this procedure achieved within the national health services (NHS) settings have not been reported, and the question of whether the published results are reproducible outside explanatory trials is yet to be answered.

The primary aim of the study is to report on functional outcomes following MI SIJ fusion, adding to the available literature. Secondary outcomes include complication rate, secondary procedure rate, and a radiological assessment of fusion would highlight challenges with diagnosis, surgical technique, and follow-up.

Materials and methods

We reviewed the treatment outcomes of 20 consecutive patients treated at a single NHS trust and a local private hospital between January 2019 and March 2021. The mean follow-up was 19.9 ± 3.4 standard deviation (SD) months with a minimum follow-up of 14 months.

Patients were referred with chronic low back pain resistant to conservative management for at least six months. The mean age at the time of surgery was 49.6 ± 14.5 SD years. Fifteen patients (75%) were females. Seven patients (35%) had previous lumbar surgery, six patients (30%) had a history of hip pathology or replacement, and two patients (10%) previously had a contralateral SIJ fusion (Table 2).

Patients were diagnosed as either dynamic sacroiliac dysfunction or degenerative sacroiliitis using history, physical examination, and a positive SI block. The main symptom was pain localizing to SIJ using the Fortin finger test [12]. An examination of SI, hip, and spine, in addition to a limb length assessment was performed in all patients. SI provocative tests were used [13]. X-rays of the pelvis and lumbar spine were performed in all patients to rule out a primary hip or spine cause. An MRI of the lumbar spine was obtained if felt clinically needed.

When symptoms, examination, and imaging pointed towards the SIJ, patients were sent for a diagnostic computed tomography (CT) guided SI injection. A 50% reduction in visual analog score (VAS) right after the procedure was considered the threshold to confirm the SIJ as the primary pain generator [6].

Conservative management was maximized, which included personalized physiotherapy, multiple SI injections, and radiofrequency ablation. Patients with a VAS score of more than 50, an oswestry disability index (ODI) of more than 30, and a positive response to injection failing conservative management were offered MI SI fusion using the iFuse® implant (SI Bone, California USA) [6].

The iFuse® is a triangular-shaped titanium implant with a porous plasma spray coating. It relies on interference fit for initial stability and has a large surface area to promote bone ingrowth to create bony bridges across the SI joint [14].

The procedures were performed by three consultants with expertise in sacroiliac screw placement. Under a general anesthetic with the patient in a supine position on a radiolucent table, a 3 cm lateral skin incision superimposed on the lateral sacral projection is performed. This is followed by a blunt division of gluteal fascia and muscles to reach the outer table of the ilium. Three guide wires were inserted under image guidance in the inlet, outlet, and lateral view corridor across the sacroiliac joint at the level of the S1 body, S1 foramen, and S2 body, respectively. The first wire is placed using a freehand technique as described for iliosacral screw placement [15]. Subsequent wires are inserted using a pin guide system utilizing the first wire as a reference. This is followed by drilling, broaching, and insertion of implant through a soft tissue protection sleeve. The incision is irrigated and closed in layers using absorbable stitches [14, 16]. Patients were kept partial weight bearing for 6 weeks. Follow-up scheduled at 6 weeks and 1 year.

Primary outcome measure

The pain was assessed using VAS, functional outcome using ODI, and quality of life using short form 36 (SF36) [17, 18]. The scores were collected preoperatively and at 1 year. The MCID for VAS and ODI was set at a reduction of 20 points and 15%, respectively [17, 19].

Secondary outcome measures

Complications and secondary procedures were recorded up until the final follow-up. Radiological assessment using a pelvis AP X-ray obtained at 1 year and a CT scan when clinically indicated (Figure 1).

thumbnail Figure 1

Axial cuts of a CT scan showing sacrum and both sacroiliac joints, note the implant breaches the left sacroiliac corridor anteriorly.

Data were coded and entered using graph pad prism version 9. Data were summarized using mean and standard deviation (SD) and using frequency (count) and relative frequency (percentage) for categorical data. Comparisons between quantitative variables were made using the paired student T-tests. p-Values less than 0.05 were considered statistically significant.

Results

An overall improvement in pain and functional outcome was observed. The VAS score improved from a mean of 81.25 ± 10.7 preoperatively to 52.5 ± 26.8 at one year, p-value of 0.0013. The mean ODI improved from 54.8 ± 11.21 SD preoperatively to 41.315 ± 15.34, p-Value = 0.0079. However, only eleven patients (55%) and 10 patients (50%) achieved the MCID for VAS and ODI, respectively.

The quality of life assessed by SF36 improved at 1 year. The mean physical component section (PCS) of SF36 improved from 28.9 preoperatively to 45.6, and the mean mental component section (MCS) changed from 35.3 to 55.85 at one year.

A complication requiring a secondary procedure occurred in two patients (10%). Both patients developed radicular pain due to a breaching implant. One patient had an implant removal, and the other had a selective nerve root block (Figure 2).

thumbnail Figure 2

Ap X-ray of a pelvis, showing 1 year follow of left sacroiliac fusion, note absence of lysis or displacement, this was considered a radiological success.

An overall secondary procedure rate of 35% was observed. In addition to the aforementioned two patients, five patients (25%) presented with recurrent low back pain; one patient required an L4–L5 fusion, 3 required a facet injection, and one needed a secondary sacroiliac injection.

We found it difficult to confirm fusion on X-rays at the one-year mark; however, absence of significant displacement, implant breaches, or loosening was considered a radiological success (75% of patients) (Figure 2). Three patients had a screw breaching the bony corridors. Eight patients had a postoperative CT scan; 2 of them showed sacral osteolysis around the tip of the implant, and both had poor VAS and ODI scores at one year (Figure 3).

thumbnail Figure 3

Axial cuts of a CT scan of pelvis, showing sacral osteolysis around caudal implants on the left side.

Discussion

The sacroiliac joint is a well-recognized cause of low back pain [3]. Surgical management through minimally invasive fusion is rapidly emerging as the standard of care for resistant cases [7, 20]. We presented our results using the iFuse® system with a minimum follow of 14 months. A statistically significant improvement in pain and functional outcomes was achieved, with only 55% and 50% achieving MCID using VAS and ODI, respectively. A 10% complication rate and a 35% secondary procedures rate were noted during the follow-up.

The study limitation is the small sample size and the lack of a comparative group. To our knowledge, this is the first study to report its outcomes achieved in day-to-day practice within the NHS setting with no conflict of interest.

The iFuse® system for MI SIJ fusion is the most widely published method. There are two randomized controlled trials [2, 6], one multicentric prospective case series [21], three retrospective comparative studies [7–9], and 4 case series reporting their results using it [14, 16, 22, 23] (Table 1).

Table 1

Listing published work on MI SIJ fusion using iFuse® implant.

This study’s diagnostic algorithm mirrors published studies (Table 1). All the studies relied on clinical examination and a positive response to a sacroiliac injection. This is based on criteria set by the International Association for the Study of Pain (IASP) [13]. These criteria are subjective and not 100% sensitive or specific [13, 24].

As the procedure is relatively new, it is unclear in the literature what the threshold is to offer fusion. In this study, conservative management was exhausted before offering surgery as a salvage procedure. A threshold of a VAS score of 50 and an ODI of 30 was used based on the work of Polly et al. In his trial, 84.4% of the conservative cohort failed conservative treatment and went on to undergo fusion after 6 months. This could serve as an estimate of how often fusion is required in cases crossing the threshold [6].

This study’s patient’s preoperative data are well matched to published studies with regard to age, sex, BMI, and functional status (Tables 2 and 3). A common feature is the high prevalence of previous lumbar surgery and the long duration of symptoms prior to surgery. An average preoperative ODI between 42 and 57.2 reflects the severe disability caused by SI pain (Table 3).

Table 2

Shows the demographics of this study’s patients compared to similar work.

Table 3

List functional outcome reported on MI SI fusion using iFuse implant.

The mean improvement in functional scores and percentage of patients achieving MCID in this study is lower than the available literature (Table 3). This can be attributed to the diagnostic challenges, smaller population, and a higher complication rate. Twenty to thirty consecutive cases are needed to overcome complications in minimally invasive spine surgeries; whether the same learning curve applies to SI fusion is still to be proven [25]. Our operative cohort still had a more favorable outcome than the conservative cohorts in the Investigation of Sacroiliac Fusion Treatment (INSITE) and iFuse® Minimally Invasive Arthrodesis (iMIA) trials [2, 6].

The iFuse® implant design adds to the stability of fixation but decreases the margin of error during its insertion. Its cross-section is formed of an equilateral triangle, with each limb measuring 11.35 mm. This is substantially bigger than the biggest sacroiliac trauma screw at 8.0 mm. In this study, 10% of patients had an implant breech requiring a secondary procedure compared to 6% in the Rudolf et al. case series [14]. Dengler et al. had a higher rate of radiological breaches (32%), but only 1 case was symptomatic and required a secondary procedure [2]. Polly et al., Cummings et al., Smith et al., and Duhon et al. reported secondary procedures for implant-related nerve impingement requiring revision surgery [6, 9, 21, 22].

The difficulty in instrumentation is further complicated by the sacral morphology. The dysmorphic sacrum bony corridor is more inclined superiorly in the frontal plane and anteriorly in the axial plane [26] (Figure 4). In this study, 40% of patients had at least one feature of dysmorphia, as described by Kaiser et al. [26]. The starting point and trajectory should be adjusted to match the plane of the SI corridor. Falzarno et al. reported the use of 3D navigation in iliosacral screw placement with low complications [27]. Polly et al. reported the use of 3d navigation in 2 centers in the INSITE trial, the safety of this subgroup had not been published separately [6].

thumbnail Figure 4

CT scan showing coronal cuts along axis of a dysmorphic sacrum. Note the high angulation of sacral alar and big neural foramina. The implant fixation was limited to Dennis I zone to allow for safe placement of implant.

Differentiation of SIJ pain from lumbosacral pathology proved challenging and can be a cause for secondary procedures. In this study, four patients (20%) represented after fusion with the pain believed to be from lumbosacral pathology. This is not unique to our study, Sachs et al. reported that 20% of his cohort represented facet joint pain [16]. It is difficult to determine whether these patients had a false positive response to the injection leading to an inaccurate diagnosis of SI as the main pain generator or whether these symptoms are due to secondary load transfer from the fused SI to the lumbar spine.

The lack of an imaging modality to confirm the diagnosis adds to the difficulty with standard cross-sectional studies being of limited utility [28]. Cusi et al. compared the single photon emission computed tomography (SPECT)/CT results to a clinical diagnosis of SI dysfunction based on provocative testing and reported 95% sensitivity and 99% sensitivity. In our study and all similar work, we have not used this modality as it is unvalidated against the response to sacroiliac injection, which is considered the gold standard [13]. We have used it selectively in patients with persistent symptoms after the procedure (Figure 5).

thumbnail Figure 5

Coronal cut of a SPECT/CT showing cold right SI joint with metalwork insitu and a warm L4–L5 disc space. The patient later underwent L4–L5 fusion.

Radiological evaluation of fusion proved to be difficult on X-ray and CT scans. This has been echoed by Dengler et al. [2] and Duhon et al. [21]. The lack of implant breakage, migration, and lysis was considered a radiological success [2]. Sacral osteolysis noted on follow-up CT was also reported by Dengler et al. (15.1%). However, none of these patients had clinical signs attributed to that [2].

There is no consensus on the depth of implant insertion. Dengler et al. found no correlation between the length of implants and clinical results [2]. Duhon et al. reported on 17 implants with lysis, and almost all of them happened when there was less than 1 cm of the implant into the sacrum (21). In our study the length of the S1 implant was dictated by the safety of insertion. The narrowest diameter of the corridor is at the mid-alar area corresponding to Dennis zone II [26]. The fixation was limited to zone I when safety was in question (Figure 4).

No revisions were performed for the suspected failure of the fusion at the time of final follow-up. Duhon et al. reported 4 revisions for the suboptimal placement of implants [21]. Polly et al. and Dengler et al. had 1 revision each for suboptimal placement [2, 6]. No clear definition was given for what is considered suboptimal placement. The outcome of the revised patients has not been reported.

Our study sample size, heterogenicity of population, lack of comparative and high rate of complications did not allow for analysis of predictors of success. Dengler et al. performed a large meta analysis on two randomized controlled trials and a large multicentric prospective case series. The study reported better outcomes in nonsmokers, non-opioid users, older age groups, and longer pain duration [20].

Surgeons performing these procedures should be aware of the challenges with diagnosing the pathology and the challenges with safe implant positioning. Further work is needed to determine the utility of SPECT/CT in the primary diagnosis. Familiarity with instrumentation, surgical planning using cross-sectional imaging, and the use of 3d navigation could help increase the safety profile of the procedure.

In conclusion, the diagnosis and treatment of SI pain remains a difficult topic. Our results have shown that fusing SI joints is a difficult operation performed often in patients with chronic pain symptoms. However, all patients improved after SIJ fusion, some more so than others. There was a significant secondary procedure rate. We believe that most patients who did poorly fell into one of three groups, wrong diagnosis, a complication, or another condition that resulted in a poor outcome, such as failed back syndrome. Further work is needed to help identify patients who will have the best results from this surgery.

Conflict of interest

MHA certifies that he has no financial conflict of interest. WA certifies that he has no financial conflict of interest. SAK certifies that he has no financial conflict of interest. KFMA certifies that he has no financial conflict of interest. MAC certifies that he has no financial conflict of interest. JG certifies that he has no financial conflict of interest. PMS certifies that he has no financial conflict of interest.

Funding

The research did not receive any specific funding.

Ethical approval

Ethical approval was not required.

Informed consent

Written informed consent was obtained from all patients for the procedure, and oral consent for the collection of functional scores and use of their data.

Author contribution

MHA data collection, writing up of original draft, and analysis. WA writing up, editing, and analysis. SAK reviewing and editing. KFMA supervision and conceptualization. MAC clinical contribution. JG clinical contribution. PMS conceptualization, supervision, clinical contribution, reviewing, and editing.

References

  1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet 380(9859), 2163–2196. [CrossRef] [PubMed] [Google Scholar]
  2. Dengler J, Kools D, Pflugmacher R, Gasbarrini A, Prestamburgo D, Gaetani P, Cher D, Van Eeckhoven E, Annertz M, Sturesson B (2019) Randomized trial of sacroiliac joint arthrodesis compared with conservative management for chronic low back pain attributed to the sacroiliac joint. J Bone Joint Surg Am 101(5), 400–411. [CrossRef] [PubMed] [Google Scholar]
  3. Cher D, Polly D, Berven S (2014) Sacroiliac joint pain: Burden of disease. Med Devices (Auckl) 7, 73–81. [PubMed] [Google Scholar]
  4. Dutta K, Dey S, Bhattacharyya P, Agarwal S, Dev P (2018) Comparison of efficacy of lateral branch pulsed radiofrequency denervation and intraarticular depot methylprednisolone injection for sacroiliac joint pain. Pain Physician 21(5), 489–496. [PubMed] [Google Scholar]
  5. Juch JNS, Maas ET, Ostelo RWJG, Groeneweg JG, Kallewaard JW, Koes BW, Verhagen AP, van Dongen JM, Huygen FJPM, van Tulder MW (2017) Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain: The mint randomized clinical trials. JAMA 318(1), 68–81. [CrossRef] [PubMed] [Google Scholar]
  6. Polly DW, Swofford J, Whang PG, Frank CJ, Glaser JA, Limoni RP, Cher DJ, Wine KD, Sembrano JN, INSITE Study Group (2016) Two-year outcomes from a randomized controlled trial of minimally invasive sacroiliac joint fusion vs. non-surgical management for sacroiliac joint dysfunction. Int J Spine Surg 10, 28. [CrossRef] [PubMed] [Google Scholar]
  7. Vanaclocha V, Herrera JM, Sáiz-Sapena N, Rivera-Paz M, Verdú-López F (2018) Minimally invasive sacroiliac joint fusion, radiofrequency denervation, and conservative management for sacroiliac joint pain: 6-year comparative case series. Neurosurgery 82(1), 48–55. [CrossRef] [PubMed] [Google Scholar]
  8. Ledonio CG, Polly DW Jr., Swiontkowski MF (2014) Minimally invasive versus open sacroiliac joint fusion: Are they similarly safe and effective? Clin Orthop Relat Res 472(6), 1831–1838. [CrossRef] [PubMed] [Google Scholar]
  9. Smith AG, Capobianco R, Cher D, Rudolf L, Sachs D, Gundanna M, Kleiner J, Mody MG, Shamie AN (2013) Open versus minimally invasive sacroiliac joint fusion: A multi-center comparison of perioperative measures and clinical outcomes. Ann Surg Innov Res 7(1), 14. [CrossRef] [PubMed] [Google Scholar]
  10. Tran ZV, Ivashchenko A, Brooks L (2019) Sacroiliac joint fusion methodology – minimally invasive compared to screw-type surgeries: A systematic review and meta-analysis. Pain Physician 22(1), 29–40. [CrossRef] [Google Scholar]
  11. Shamrock AG, Patel A, Alam M, Shamrock KH, Al Maaieh M (2019) The safety profile of percutaneous minimally invasive sacroiliac joint fusion. Global Spine J 9(8), 874–880. [CrossRef] [PubMed] [Google Scholar]
  12. Fortin JD, Falco FJ (1997) The Fortin finger test: An indicator of sacroiliac pain. Am J Orthop (Belle Mead NJ) 7, 477–480. [Google Scholar]
  13. Szadek KM, van der Wurff P, van Tulder MW, Zuurmond WW, Perez RS (2009) Diagnostic validity of criteria for sacroiliac joint pain: A systematic review. J Pain 10(4), 354–368. [CrossRef] [PubMed] [Google Scholar]
  14. Rudolf L (2012) Sacroiliac joint arthrodesis-MIS technique with titanium implants: Report of the first 50 patients and outcomes. Open Orthop J 6, 495–502. [CrossRef] [PubMed] [Google Scholar]
  15. Krappinger D, Lindtner RA, Benedikt S (2019) Preoperative planning and safe intraoperative placement of iliosacral screws under fluoroscopic control. Oper Orthop Traumatol 31(6), 465–473. [CrossRef] [PubMed] [Google Scholar]
  16. Sachs D, Capobianco R, Cher D, Holt T, Gundanna M, Graven T, Shamie AN, Cummings J Jr. (2014) One-year outcomes after minimally invasive sacroiliac joint fusion with a series of triangular implants: A multicenter, patient-level analysis. Med Devices (Auckl) 7, 299–304. [PubMed] [Google Scholar]
  17. Copay AG, Cher DJ (2016) Is the Oswestry disability index a valid measure of response to sacroiliac joint treatment? Qual Life Res 25(2), 283–292. [CrossRef] [PubMed] [Google Scholar]
  18. Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ 305(6846), 160–164. [CrossRef] [PubMed] [Google Scholar]
  19. Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY (2008) Minimum clinically important difference in lumbar spine surgery patients: A choice of methods using the Oswestry disability index, medical outcomes study questionnaire short form 36, and pain scales. Spine J 8(6), 968–974. [CrossRef] [PubMed] [Google Scholar]
  20. Dengler J, Duhon B, Whang P, Frank C, Glaser J, Sturesson B, Garfin S, Cher D, Rendahl A, Polly D, INSITE, iMIA, SIFI study groups (2017) Predictors of outcome in conservative and minimally invasive surgical management of pain originating from the sacroiliac joint: A pooled analysis. Spine (Phila Pa 1976) 42(21), 1664–1673. [CrossRef] [PubMed] [Google Scholar]
  21. Duhon BS, Bitan F, Lockstadt H, Kovalsky D, Cher D, Hillen T, SIFI Study Group (2016) Triangular titanium implants for minimally invasive sacroiliac joint fusion: 2-year follow-up from a prospective multicenter trial. Int J Spine Surg 10, 13. [CrossRef] [PubMed] [Google Scholar]
  22. Cummings J Jr., Capobianco RA (2013) Minimally invasive sacroiliac joint fusion: One-year outcomes in 18 patients. Ann Surg Innov Res 7(1), 12. [CrossRef] [PubMed] [Google Scholar]
  23. Gaetani P, Miotti D, Risso A, Bettaglio R, Bongetta D, Custodi V, Silvani V (2013) Percutaneous arthrodesis of sacro-iliac joint: A pilot study. J Neurosurg Sci 57(4), 297–301. [PubMed] [Google Scholar]
  24. Kennedy DJ, Engel A, Kreiner DS, Nampiaparampil D, Duszynski B, MacVicar J (2015) Fluoroscopically guided diagnostic and therapeutic intra-articular sacroiliac Joint injections: A systematic review. Pain Med 16(8), 1500–1518. [CrossRef] [PubMed] [Google Scholar]
  25. Sclafani JA, Kim CW (2014) Complications associated with the initial learning curve of minimally invasive spine surgery: A systematic review. Clin Orthop Relat Res 472(6), 1711–1717. [CrossRef] [PubMed] [Google Scholar]
  26. Kaiser SP, Gardner MJ, Liu J, Routt ML Jr., Morshed S (2014) Anatomic determinants of sacral dysmorphism and implications for safe iliosacral screw placement. J Bone Joint Surg Am 96(14), e1201–e1208. [CrossRef] [PubMed] [Google Scholar]
  27. Falzarano G, Rollo G, Bisaccia M, Pace V, Lanzetti RM, Garcia-Prieto E, Pichierri P, Meccariello L (2018) Percutaneous screws CT guided to fix sacroiliac joint in tile C pelvic injury: Outcomes at 5 years of follow-up. SICOT J 4, 52. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  28. Cusi M, Saunders J, Van der Wall H, Fogelman I (2013) Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence. Eur Spine J 22(7), 1674–1682. [CrossRef] [PubMed] [Google Scholar]

Cite this article as: Amer MH, Elnahal WA, Khaled SA, Abdel-Kader KFM, Cass MA, Gibbs J & Stott PM (2022) Minimally invasive sacroiliac fusion, a case series, and a literature review. SICOT-J 8, 42

All Tables

Table 1

Listing published work on MI SIJ fusion using iFuse® implant.

In the text
Table 2

Shows the demographics of this study’s patients compared to similar work.

In the text
Table 3

List functional outcome reported on MI SI fusion using iFuse implant.

In the text

All Figures

thumbnail Figure 1

Axial cuts of a CT scan showing sacrum and both sacroiliac joints, note the implant breaches the left sacroiliac corridor anteriorly.
In the text
thumbnail Figure 2

Ap X-ray of a pelvis, showing 1 year follow of left sacroiliac fusion, note absence of lysis or displacement, this was considered a radiological success.
In the text
thumbnail Figure 3

Axial cuts of a CT scan of pelvis, showing sacral osteolysis around caudal implants on the left side.
In the text
thumbnail Figure 4

CT scan showing coronal cuts along axis of a dysmorphic sacrum. Note the high angulation of sacral alar and big neural foramina. The implant fixation was limited to Dennis I zone to allow for safe placement of implant.
In the text
thumbnail Figure 5

Coronal cut of a SPECT/CT showing cold right SI joint with metalwork insitu and a warm L4–L5 disc space. The patient later underwent L4–L5 fusion.
In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.